AI Article Synopsis
- A case of uveal effusion syndrome was reported in a 56-year-old woman with angle closure glaucoma following a primary COVID-19 infection.
- Imaging showed bilateral uveal effusions and choroidal thickening, which led to specific treatments including iridotomies and oral steroids.
- This case highlights the importance of recognizing uveal effusion syndrome as a potential complication of COVID-19 infection, aiding in future diagnosis and management.
Article Abstract
Purpose: To report a case of uveal effusion syndrome in association with primary COVID-19 infection to share our experience and insight in diagnosing and managing this unique case.
Case Presentation: A 56-year-old woman presented with angle closure glaucoma of both eyes. Further examination and imaging revealed the etiology to be related to bilateral uveal effusions and choroidal thickening in the setting of recent COVID-19 infection. The patient's glaucoma was managed with bilateral iridotomies and medical therapy, while the precipitating uveal effusions resolved with treatment on oral steroids.
Conclusion: While uveal effusion syndrome has been associated with COVID-19 vaccination, it has not yet been reported after primary infection. Recognition of this rare phenomenon will allow for better diagnosis and treatment in future cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/08820538.2024.2381771 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!